A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID‐19
Nisrein Jaber, Mayyas Al‐Remawi, Faisal Al‐Akayleh, Najah Al‐Muhtaseb, I.S.I. Al-Adham, P.J. Collier
Abstract
Chitosan is an abundant organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct antiviral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the treatment of endemic SARS-CoV-2.
Topics & Concepts
PharmacyCoronavirus disease 2019 (COVID-19)Library scienceMedicineFamily medicineComputer scienceInternal medicineDiseaseInfectious disease (medical specialty)Biosensors and Analytical DetectionAntimicrobial agents and applicationsAdvanced Drug Delivery Systems